GIC announced on Wednesday (Dec 18) that it will be investing an additional US$150 million into Asia Healthcare Holdings (AHH), a healthcare delivery platform from South Asia.
This comes after the city state’s sovereign wealth fund’s first investment of US$170 million in AHH earlier in February 2022.
Founded in 2016, AHH is a single specialty investing and operating healthcare platform backed by GIC and TPG Growth, the growth equity and smaller buyout investment arm of TPG Capital.
Its platform today includes Motherhood hospitals, fertility solutions provider Nova in-vitro fertilisation (IVF), and Asian Institute of Nephrology and Urology (AINU) hospitals.
Motherhood is a pan-India chain of mother and childcare hospitals offering comprehensive services from pre-conception to post-birthing care for women, a range of services under pediatric care, and the largest network of neonatal intensive care units.
AINU is India’s only Urology and Nephrology specialty hospital network recognised for urological care, including robotic surgery and high-end nephrology procedures.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
To date, AHH has invested around US$300 million across hospital chains in the areas of oncology, mother and childcare, urology and nephrology, and IVF and fertility under the daycare specialty.
Vishal Bali, executive chairman of AHH, said that the company was started as a healthcare delivery platform that would invest, transform and grow single specialty enterprises under one holding company,
“Over the years, our differentiated investment approach has since delivered strong growth opportunities to bridge the demand-supply gap of healthcare services in India,” he added.
Choo Yong Cheen, chief investment officer of private equity at GIC said, “As a long-term investor, we are confident in India’s single specialty healthcare sector, which has strong tailwinds for growth driven by increasing per capita income, urbanisation, high awareness of specialty care, and improved supply of high-quality clinics. AHH’s potential to expand into newer sub-segments positions it well for continued success.”
